| 1 | Low-Dose Colchicine Attenuates Clonal Hematopoiesis in COLCOT. | 2026 | 24.7 | 8 | Citations (PDF) |
| 2 | Timing of Statin Dose: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. | 2022 | 6.2 | 3 | Citations (PDF) |
| 3 | Pharmacogenetics-Guided Dalcetrapib Therapy After an Acute Coronary Syndrome: The Dal-GenE Trial | 2022 | 14.8 | 37 | Citations (PDF) |
| 4 | Myocardial Infarction in the ISCHEMIA Trial | 2021 | 24.7 | 135 | Citations (PDF) |
| 5 | Cost-Effectiveness of Low-Dose Colchicine After Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT) | 2021 | 4.9 | 77 | Citations (PDF) |
| 6 | Notes From Cardiology Clinic: Trouble for Tongans | 2021 | 3.8 | 1 | Citations (PDF) |
| 7 | Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT | 2021 | 4.0 | 17 | Citations (PDF) |
| 8 | The Association Between Lipid Levels and Leukocyte Count: A Cross-Sectional and Longitudinal Analysis of Three Large Cohorts | 2021 | 2.1 | 12 | Citations (PDF) |
| 9 | Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib | 2021 | 4.0 | 10 | Citations (PDF) |
| 10 | Notes From Cardiology Clinic: Mitral Stenosis and Racial Discordance | 2021 | 3.8 | 0 | Citations (PDF) |
| 11 | Notes From Cardiology Clinic: Cinderella’s Electronic Medical Record | 2021 | 3.8 | 0 | Citations (PDF) |
| 12 | Changing the Face of Cardiovascular Trial Participation: Moving Beyond Middle-Aged White Guys | 2021 | 1.8 | 1 | Citations (PDF) |
| 13 | Usefulness of Angina to Guide Revascularization Decisions | 2021 | 24.7 | 1 | Citations (PDF) |
| 14 | Notes From Cardiology Clinic: You Can't Ride With the Cops, but Cheer for the Robbers | 2021 | 3.8 | 0 | Citations (PDF) |
| 15 | Colchicine for Community-Treated Patients With COVID-19 (COLCORONA): A Phase 3, Randomised, Double-Blinded, Adaptive, Placebo-Controlled, Multicentre Trial | 2021 | 28.0 | 293 | Citations (PDF) |
| 16 | Notes From Cardiology Clinic: The Patients We Dislike | 2020 | 3.8 | 0 | Citations (PDF) |
| 17 | Notes From Cardiology Clinic: The Patients We Dislike. | 2020 | 3.8 | 0 | Citations (PDF) |
| 18 | When Diastole Lets You Down: Clinical Relevance of a Widened Pulse Pressure | 2020 | 3.8 | 1 | Citations (PDF) |
| 19 | Notes From Cardiology Clinic: Health Care Heroine, Unpaid and Unappreciated | 2020 | 3.8 | 0 | Citations (PDF) |
| 20 | Notes From Cardiology Clinic: The Heartbreaking Risk Factor We Overlook | 2020 | 3.8 | 0 | Citations (PDF) |
| 21 | Time-to-Treatment Initiation of Colchicine and Cardiovascular Outcomes After Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT) | 2020 | 14.8 | 307 | Citations (PDF) |
| 22 | Will Colchicine Soon Be Part of Primary and Secondary Cardiovascular Prevention? | 2020 | 3.8 | 7 | Citations (PDF) |
| 23 | Notes From the Cardiology Clinic: Facing Down the Dragons of Health Anxiety | 2020 | 3.8 | 0 | Citations (PDF) |
| 24 | Notes From Cardiology Clinic: Brittle Bones and Blue Sclerae | 2020 | 3.8 | 0 | Citations (PDF) |
| 25 | Study Design of Dal-GenE, a Pharmacogenetic Trial Targeting Reduction of Cardiovascular Events With Dalcetrapib | 2020 | 3.4 | 30 | Citations (PDF) |
| 26 | Inflammation in Cardiovascular Disease: From Basic Concepts to Clinical Application | 2020 | 0.5 | 1 | Citations (PDF) |
| 27 | Cholesterol Lowering Guidelines: From Whence We Came and Where We Are Now | 2019 | 3.8 | 7 | Citations (PDF) |
| 28 | Improving Statin Noncompliance: If You Build It, Will They Come? | 2019 | 3.8 | 4 | Citations (PDF) |
| 29 | Notes From Cardiology Clinic: When Our Responsibilities Extend Beyond the Patient | 2019 | 3.8 | 1 | Citations (PDF) |
| 30 | Notes From Cardiology Clinic: Woman, Lost During Follow-Up. | 2019 | 3.8 | 0 | Citations (PDF) |
| 31 | HIV Infection and Coronary Heart Disease: Mechanisms and Management | 2019 | 62.6 | 210 | Citations (PDF) |
| 32 | Atorvastatin Has a Dose‐Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double‐Blind Randomized Controlled Trials | 2019 | 5.8 | 30 | Citations (PDF) |
| 33 | Introduction to Cardiovascular Issues in HIV | 2019 | 3.8 | 1 | Citations (PDF) |
| 34 | Efficacy and Safety of Low-Dose Colchicine After Myocardial Infarction | 2019 | 76.8 | 3,055 | Citations (PDF) |
| 35 | Lipid Abnormalities in Persons Living With HIV Infection | 2019 | 3.8 | 66 | Citations (PDF) |
| 36 | High Plasma FGF21 Levels Predicts Major Cardiovascular Events in Patients Treated With Atorvastatin (From the Treating to New Targets [TNT] Study) | 2019 | 16.0 | 35 | Citations (PDF) |
| 37 | Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial | 2018 | 24.7 | 179 | Citations (PDF) |
| 38 | Relationship of High‐Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin | 2018 | 5.8 | 7 | Citations (PDF) |
| 39 | Visit-to-Visit Variability of Lipid Measurements as Predictors of Cardiovascular Events | 2018 | 4.7 | 57 | Citations (PDF) |
| 40 | Variations in Time to Benefit Among Clinical Trials of Cholesterol-Lowering Drugs | 2018 | 4.7 | 30 | Citations (PDF) |
| 41 | Lipids, Inflammation, and Chronic Kidney Disease: A SHARP Perspective | 2018 | 12.9 | 7 | Citations (PDF) |
| 42 | Effect of Atorvastatin, Cholesterol Ester Transfer Protein Inhibition, and Diabetes Mellitus on Circulating Proprotein Subtilisin Kexin Type 9 and Lipoprotein(a) Levels in Patients at High Cardiovascular Risk | 2018 | 4.7 | 58 | Citations (PDF) |
| 43 | RE: Praluent (Alirocumab)-Induced Renal Injury | 2018 | 1.3 | 1 | Citations (PDF) |
| 44 | Body Weight Variability and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus | 2018 | 5.6 | 72 | Citations (PDF) |
| 45 | Time to Recognize HIV Infection as a Major Cardiovascular Risk Factor | 2018 | 24.7 | 110 | Citations (PDF) |
| 46 | PCSK9 Inhibition to Reduce Cardiovascular Risk | 2017 | 15.7 | 16 | Citations (PDF) |
| 47 | Body-Weight Fluctuations and Outcomes in Coronary Disease | 2017 | 76.8 | 289 | Citations (PDF) |
| 48 | An Evidence-Based Guide to Cholesterol-Lowering Guidelines | 2017 | 3.8 | 18 | Citations (PDF) |
| 49 | Taking Hockey to Heart: Potential Coronary Risks of Watching Exciting Games | 2017 | 3.8 | 2 | Citations (PDF) |
| 50 | Heart Failure in Persons Living With HIV Infection | 2017 | 3.6 | 41 | Citations (PDF) |
| 51 | Are Cholesterol Treatment Targets a Deterrent to Optimal Lipid-Lowering Therapy? | 2017 | 16.4 | 1 | Citations (PDF) |
| 52 | The Evolution of Myocardial Infarction: When the Truths We Hold to Be Self-Evident No Longer Have Evidence | 2017 | 3.8 | 4 | Citations (PDF) |
| 53 | Body-Weight Fluctuations and Outcomes in Coronary Disease | 2017 | 76.8 | 18 | Citations (PDF) |
| 54 | The Rise and Fall of Tuberculosis and Atherosclerosis: First There Is a Mountain… | 2017 | 3.8 | 4 | Citations (PDF) |
| 55 | Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction From the IDEAL Trial | 2017 | 2.5 | 66 | Citations (PDF) |
| 56 | Tribulations of Recent Cardiology Trials, the Audacity of Hope, and HOPE-3 | 2016 | 3.8 | 1 | Citations (PDF) |
| 57 | PCSK9 Inhibitors for Statin Intolerance? | 2016 | 37.2 | 21 | Citations (PDF) |
| 58 | Metabolic Markers to Predict Incident Diabetes Mellitus in Statin-Treated Patients (From the Treating to New Targets and the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trials) | 2016 | 2.5 | 18 | Citations (PDF) |
| 59 | Performance Deficiencies in the Treatment of ST-Elevation Myocardial Infarction in Québec: “Tis but a Part We See, and Not a Whole” | 2016 | 3.8 | 0 | Citations (PDF) |
| 60 | Emerging Cardiovascular Disease Biomarkers and Incident Diabetes Mellitus Risk in Statin-Treated Patients With Coronary Artery Disease (From the Treating to New Targets [TNT] Study). | 2016 | 2.5 | 8 | Citations (PDF) |
| 61 | 2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis? | 2016 | 3.2 | 46 | Citations (PDF) |
| 62 | Predicting Prognosis in Acute Coronary Syndromes: Makeover Time for TIMI and GRACE? | 2016 | 3.8 | 9 | Citations (PDF) |
| 63 | Statin-Centric Versus Low-Density Lipoprotein-Centric Approach for Atherosclerotic Cardiovascular Disease Prevention: A Singapore Perspective. | 2016 | 1.6 | 8 | Citations (PDF) |
| 64 | LDL-Cholesterol Lowering and Renal Outcomes | 2015 | 5.0 | 14 | Citations (PDF) |
| 65 | Doctors' Knowledge, Attitudes, and Compliance With 2013 ACC/AHA Guidelines for Prevention of Atherosclerotic Cardiovascular Disease in Singapore | 2015 | 3.7 | 29 | Citations (PDF) |
| 66 | Risk of New-Onset Diabetes and Cardiovascular Risk Reduction From High-Dose Statin Therapy in Pre-Diabetics and Non–Pre-Diabetics: An Analysis From TNT and IDEAL | 2015 | 12.1 | 40 | Citations (PDF) |
| 67 | Impact of Female Sex on Lipid Lowering, Clinical Outcomes, and Adverse Effects in Atorvastatin Trials | 2015 | 2.5 | 57 | Citations (PDF) |
| 68 | Reply: Statin-Induced Low Low-Density Lipoprotein Cholesterol Level: Is Lower Better? | 2015 | 12.1 | 1 | Citations (PDF) |
| 69 | The Effect of Statin Therapy on Heart Failure Events: A Collaborative Meta-Analysis of Unpublished Data From Major Randomized Trials. | 2015 | 14.8 | 155 | Citations (PDF) |
| 70 | PCSK9 Inhibition to Lower LDL-Cholesterol and Reduce Cardiovascular Risk | 2015 | 15.7 | 9 | Citations (PDF) |
| 71 | HMG-Coenzyme A Reductase Inhibition, Type 2 Diabetes, and Bodyweight: Evidence From Genetic Analysis and Randomised Trials | 2015 | 97.2 | 619 | Citations (PDF) |
| 72 | Prediction of Cardiovascular Events in Statin-Treated Stable Coronary Patients of the Treating to New Targets Randomized Controlled Trial by Lipid and Non-Lipid Biomarkers | 2014 | 3.2 | 45 | Citations (PDF) |
| 73 | TNT Trial | 2014 | | 0 | Citations (PDF) |
| 74 | TNT Trial | 2014 | | 0 | Citations (PDF) |
| 75 | The Past and Future of Heart Institutes: Having Moved Beyond the One-Trick Pony | 2014 | 3.8 | 4 | Citations (PDF) |
| 76 | Cardiovascular Drugs That Increase the Risk of New-Onset Diabetes | 2014 | 3.4 | 33 | Citations (PDF) |
| 77 | Impact of High-Dose Atorvastatin Therapy and Clinical Risk Factors on Incident Aortic Valve Stenosis in Patients With Cardiovascular Disease (From TNT, IDEAL, and SPARCL) | 2014 | 2.5 | 29 | Citations (PDF) |
| 78 | Looking for Coronary Disease in Patients With Atrial Fibrillation | 2014 | 3.8 | 6 | Citations (PDF) |
| 79 | Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events: A Meta-Analysis of Statin Trials | 2014 | 12.1 | 568 | Citations (PDF) |
| 80 | The Curse of Target Lesion Calcification: Still Active After All These Years. | 2014 | 12.1 | 5 | Citations (PDF) |
| 81 | Statin and the Risk of Renal-Related Serious Adverse Events: Analysis From the IDEAL, TNT, Cards, Aspen, SPARCL, and Other Placebo-Controlled Trials | 2014 | 2.5 | 39 | Citations (PDF) |
| 82 | Effect of Change in Body Weight on Incident Diabetes Mellitus in Patients With Stable Coronary Artery Disease Treated With Atorvastatin (From the Treating to New Targets Study) | 2014 | 2.5 | 27 | Citations (PDF) |
| 83 | Meta-Analyses of Statin Trials: Clear Benefit for Primary Prevention in the Elderly∗ | 2013 | 12.1 | 2 | Citations (PDF) |
| 84 | Papering Over the Cracks: Meta-Analysis to Define the Role of Percutaneous Coronary Intervention in Patients With Stable Angina | 2013 | 3.8 | 1 | Citations (PDF) |
| 85 | Reply: To PMID 23219296. | 2013 | 12.1 | 5 | Citations (PDF) |
| 86 | Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy: Effect of Baseline Risk Factors for Diabetes. | 2013 | 12.1 | 170 | Citations (PDF) |
| 87 | Determinants of Residual Risk in Secondary Prevention Patients Treated With High- Versus Low-Dose Statin Therapy | 2012 | 24.7 | 165 | Citations (PDF) |
| 88 | Utility of Biomarkers and Imaging in the Development of Drugs for the Treatment of Coronary Atherosclerosis | 2012 | 3.8 | 3 | Citations (PDF) |
| 89 | Relation of Improvement in Estimated Glomerular Filtration Rate With Atorvastatin to Reductions in Hospitalizations for Heart Failure (From the Treating to New Targets [TNT] Study) | 2012 | 2.5 | 19 | Citations (PDF) |
| 90 | Inhibition of Secretory Phospholipase A2 in Patients With Acute Coronary Syndromes: Rationale and Design of the Vascular Inflammation Suppression to Treat Acute Coronary Syndrome for 16 Weeks (VISTA-16) Trial | 2012 | 4.1 | 41 | Citations (PDF) |
| 91 | Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin: Results From 3 Large Randomized Clinical Trials. | 2011 | 12.1 | 317 | Citations (PDF) |
| 92 | Tobacco Smoke and Cardiovascular Risk: A Call for Continued Efforts to Reduce Exposure | 2011 | 2.2 | 14 | Citations (PDF) |
| 93 | On-Treatment Lipoprotein Components and Risk of Cerebrovascular Events in the Treating to New Targets Study | 2011 | 4.4 | 10 | Citations (PDF) |
| 94 | Hemodynamic and Arrhythmogenic Effects of Cocaine in Hypertensive Individuals | 2011 | 3.0 | 19 | Citations (PDF) |
| 95 | Impact of Smoking on Cardiovascular Events in Patients With Coronary Disease Receiving Contemporary Medical Therapy (From the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] Trials) | 2011 | 2.5 | 58 | Citations (PDF) |
| 96 | Effect of Torcetrapib on Glucose, Insulin, and Hemoglobin A1c in Subjects in the Investigation of Lipid Level Management to Understand Its Impact in Atherosclerotic Events (ILLUMINATE) Trial | 2011 | 24.7 | 190 | Citations (PDF) |
| 97 | Exploring New Indications for Statins Beyond Atherosclerosis: Successes and Setbacks | 2010 | 3.9 | 26 | Citations (PDF) |
| 98 | Usefulness of Heart Rate at Rest as a Predictor of Mortality, Hospitalization for Heart Failure, Myocardial Infarction, and Stroke in Patients With Stable Coronary Heart Disease (Data From the Treating to New Targets [TNT] Trial). | 2010 | 2.5 | 77 | Citations (PDF) |
| 99 | Statins Before Stents: Does an Ounce of Prevention Improve Outcomes? | 2010 | 3.8 | 0 | Citations (PDF) |
| 100 | Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients With Congestive Heart Failure and Coronary Heart Disease in the US | 2010 | 5.8 | 18 | Citations (PDF) |
| 101 | Lipid Treatment Assessment Project 2 | 2009 | 24.7 | 291 | Citations (PDF) |
| 102 | Clinical Insights From the Treating to New Targets Trial | 2009 | 9.7 | 6 | Citations (PDF) |
| 103 | Early Statin Therapy in Acute Coronary Syndromes: The Successful Cycle of Evidence, Guidelines, and Implementation. | 2009 | 12.1 | 21 | Citations (PDF) |
| 104 | A Winter’s Tale: Report From the First Annual Canadian Biomarkers and Surrogate Endpoints Symposium | 2009 | 3.8 | 3 | Citations (PDF) |
| 105 | Effects of 1-H-Indole-3-Glyoxamide (A-002) on Concentration of Secretory Phospholipase A2 (PLASMA Study): A Phase II Double-Blind, Randomised, Placebo-Controlled Trial | 2009 | 97.2 | 114 | Citations (PDF) |
| 106 | Preventing and Treating Stroke and Transient Ischemic Attack | 2008 | 2.5 | 1 | Citations (PDF) |
| 107 | Comparison of Effectiveness of Atorvastatin 10 mg Versus 80 mg in Reducing Major Cardiovascular Events and Repeat Revascularization in Patients With Previous Percutaneous Coronary Intervention (Post Hoc Analysis of the Treating to New Targets [TNT] Study) | 2008 | 2.5 | 41 | Citations (PDF) |
| 108 | Intensive Lipid-Lowering With Atorvastatin for Secondary Prevention in Patients After Coronary Artery Bypass Surgery. | 2008 | 12.1 | 91 | Citations (PDF) |
| 109 | The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): Design and Baseline Characteristics | 2008 | 11.1 | 62 | Citations (PDF) |
| 110 | Inflammation, Statin Therapy, and Risk of Stroke After an Acute Coronary Syndrome in the MIRACL Study | 2008 | 7.9 | 64 | Citations (PDF) |
| 111 | Does Prevalence of the Metabolic Syndrome in Women With Coronary Artery Disease Differ by the ATP III and IDF Criteria? | 2008 | 2.1 | 22 | Citations (PDF) |
| 112 | TNT Trial | 2008 | | 0 | Citations (PDF) |
| 113 | Effects of Torcetrapib in Patients at High Risk for Coronary Events | 2007 | 76.8 | 3,031 | Citations (PDF) |
| 114 | The SPARCL Study: Extending the Indications of Statin Therapy for Stroke? | 2007 | 8.4 | 0 | Citations (PDF) |
| 115 | Effect of High-Dose Atorvastatin on Hospitalizations for Heart Failure | 2007 | 24.7 | 157 | Citations (PDF) |
| 116 | The Editor’s Roundtable: Statin Therapy in Acute Coronary Syndrome | 2007 | 2.5 | 2 | Citations (PDF) |
| 117 | Cardiac Arrest in Patients Who Smoke Crack Cocaine | 2007 | 2.5 | 39 | Citations (PDF) |
| 118 | Treatment of Cardiovascular Manifestations of HIV | 2007 | 3.0 | 0 | Citations (PDF) |
| 119 | Effects of High-Dose Atorvastatin on Cerebrovascular Events in Patients With Stable Coronary Disease in the TNT (Treating to New Targets) Study | 2006 | 12.1 | 63 | Citations (PDF) |
| 120 | Effects of Statin Therapy on the Development and Progression of Heart Failure: Mechanisms and Clinical Trials | 2006 | 5.0 | 37 | Citations (PDF) |
| 121 | What the Statin Trials Have Taught Us | 2006 | 2.5 | 29 | Citations (PDF) |
| 122 | Increased Carotid Intima-Media Thickness in HIV Patients Is Associated With Increased Cytomegalovirus-Specific T-Cell Responses | 2006 | 2.7 | 256 | Citations (PDF) |
| 123 | Usefulness of Serum Endothelin Levels in Predicting Death and Myocardial Infarction but Not Coronary Progression in Postmenopausal Women With Coronary Disease (From the Women’s Angiographic Vitamin and Estrogen [WAVE] Study) | 2005 | 2.5 | 7 | Citations (PDF) |
| 124 | Safety of High-Dose Atorvastatin Therapy | 2005 | 2.5 | 72 | Citations (PDF) |
| 125 | Chlamydia pneumoniae and Atherosclerosis: From Koch Postulates to Clinical Trials | 2005 | 9.7 | 24 | Citations (PDF) |
| 126 | What a Cardiologist Needs to Know About Patients With Human Immunodeficiency Virus Infection | 2005 | 24.7 | 49 | Citations (PDF) |
| 127 | High-Density Lipoprotein, but Not Low-Density Lipoprotein Cholesterol Levels Influence Short-Term Prognosis After Acute Coronary Syndrome: Results From the MIRACL Trial. | 2005 | 14.8 | 192 | Citations (PDF) |
| 128 | Hormone Therapy and Antioxidant Vitamins Do Not Improve Endothelial Vasodilator Function in Postmenopausal Women With Established Coronary Artery Disease: A Substudy of the Women's Angiographic Vitamin and Estrogen (WAVE) Trial | 2005 | 7.0 | 49 | Citations (PDF) |
| 129 | Clinical Features of Acute Coronary Syndromes in Patients With Human Immunodeficiency Virus Infection | 2004 | 24.7 | 190 | Citations (PDF) |
| 130 | Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients With HIV Infection | 2004 | 24.7 | 564 | Citations (PDF) |
| 131 | Postmenopausal Hormone Therapy Is Associated With Atherosclerosis Progression in Women With Abnormal Glucose Tolerance | 2004 | 24.7 | 43 | Citations (PDF) |
| 132 | Role of Thrombotic and Fibrinolytic Factors in Acute Coronary Syndromes | 2004 | 9.7 | 35 | Citations (PDF) |
| 133 | Treating to New Targets (TNT) Study: Does Lowering Low-Density Lipoprotein Cholesterol Levels Below Currently Recommended Guidelines Yield Incremental Clinical Benefit? | 2004 | 2.5 | 185 | Citations (PDF) |
| 134 | Soluble Fibrin, C-Reactive Protein, Fibrinogen, Factor VII, Antithrombin, Proteins C and S, Tissue Factor, d-Dimer, and Prothrombin Fragment 1 + 2 in Men With Acute Myocardial Infarction ≤45 Years of Age | 2004 | 2.5 | 15 | Citations (PDF) |
| 135 | Management of the Acute Coronary Syndrome Patient | 2004 | 3.0 | 0 | Citations (PDF) |
| 136 | Lessons From the PROVE-IT Trial. Higher Dose of Potent Statin Better for High-Risk Patients. | 2004 | 2.4 | 14 | Citations (PDF) |
| 137 | Management of the Acute Coronary Syndrome Patient | 2004 | 3.0 | 0 | Citations (PDF) |
| 138 | Pharmacoeconomic Evaluation of the Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes | 2003 | 2.5 | 18 | Citations (PDF) |
| 139 | Statins and Safety: Applying the Results of Randomized Trials to Clinical Practice | 2003 | 2.5 | 11 | Citations (PDF) |
| 140 | Implications of Cigarette Smoking for the Management of Patients With Acute Coronary Syndromes | 2003 | 9.7 | 20 | Citations (PDF) |
| 141 | Differences in Medical Care and Disease Outcomes Among Black and White Women With Heart Disease | 2003 | 24.7 | 132 | Citations (PDF) |
| 142 | Women Do Benefit From Lipid Lowering: Latest Clinical Trial Data | 2003 | 1.7 | 17 | Citations (PDF) |
| 143 | Vitamins and Hormone Therapy for Coronary Atherosclerosis—Reply | 2003 | 37.2 | 0 | Citations (PDF) |
| 144 | Impact of Diabetes on the Risk Stratification Using Stress Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging in Patients With Symptoms Suggestive of Coronary Artery Disease | 2002 | 24.7 | 354 | Citations (PDF) |
| 145 | Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-Up (HERS II) | 2002 | 37.2 | 1,603 | Citations (PDF) |
| 146 | Acute Aortic Dissection Related to Crack Cocaine | 2002 | 24.7 | 200 | Citations (PDF) |
| 147 | Do Statins Confer Early Benefit After Acute Coronary Syndromes? The Results From FLORIDA. | 2002 | 14.8 | 1 | Citations (PDF) |
| 148 | Effects of Atorvastatin on Stroke in Patients With Unstable Angina or Non-Q-Wave Myocardial Infarction | 2002 | 24.7 | 184 | Citations (PDF) |
| 149 | Mechanical or Metabolic Treatment for Coronary Disease: Synergistic, Not Antagonistic, Approaches | 2002 | 1.7 | 3 | Citations (PDF) |
| 150 | Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women: A Randomized Controlled Trial | 2002 | 37.2 | 493 | Citations (PDF) |
| 151 | Estrogen Therapy for Unstable Angina: Another Bump for the Bandwagon. | 2002 | 12.1 | 6 | Citations (PDF) |
| 152 | Reassessment of National Cholesterol Education Program Adult Treatment Panel-III Guidelines: One Year Later. | 2002 | 2.5 | 2 | Citations (PDF) |
| 153 | PRINCE’s Prospects: Statins, Inflammation, and Coronary Risk | 2001 | 3.4 | 20 | Citations (PDF) |
| 154 | Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes: The MIRACL Study: A Randomized Controlled Trial | 2001 | 37.2 | 2,271 | Citations (PDF) |
| 155 | Management of a Patient With Angina Pectoris | 2001 | 5.9 | 0 | Citations (PDF) |
| 156 | A Reply | 2001 | 14.8 | 0 | Citations (PDF) |
| 157 | The Myocardial Ischemia Reduction With Acute Cholesterol Lowering (MIRACL) Trial: A New Frontier for Statins? | 2001 | 2.6 | 20 | Citations (PDF) |
| 158 | Are We Aggressive Enough in Lowering Cholesterol? | 2001 | 2.5 | 14 | Citations (PDF) |
| 159 | What Is the Role of Intensive Cholesterol Lowering in the Treatment of Acute Coronary Syndromes? | 2001 | 2.5 | 14 | Citations (PDF) |
| 160 | Early Pharmacologic Intervention and Plaque Stability in Acute Coronary Syndromes | 2001 | 2.5 | 14 | Citations (PDF) |
| 161 | What Do the Statin Trials Tell Us? | 2001 | 3.1 | 8 | Citations (PDF) |
| 162 | Low-Density-Lipoprotein Cholesterol Goals for Patients With Coronary Disease | 2001 | 24.7 | 6 | Citations (PDF) |
| 163 | Atorvastatin for Acute Coronary Syndromes | 2001 | 37.2 | 1 | Citations (PDF) |
| 164 | Atorvastatin for Acute Coronary Syndromes—Reply | 2001 | 37.2 | 0 | Citations (PDF) |
| 165 | Short- and Medium-Term Outcome Differences in Women and Men After Primary Percutaneous Transluminal Mechanical Revascularization for Acute Myocardial Infarction | 2000 | 2.5 | 24 | Citations (PDF) |
| 166 | Comparison of Electrocardiographic-Gated Technetium-99m Sestamibi Single-Photon Emission Computed Tomographic Imaging and Rest-Redistribution Thallium-201 in the Prediction of Myocardial Viability | 2000 | 2.5 | 23 | Citations (PDF) |
| 167 | Relation of C-Reactive Protein to Extent and Severity of Coronary Narrowing in Patients With Stable Angina Pectoris or Abnormal Exercise Tests | 2000 | 2.5 | 48 | Citations (PDF) |
| 168 | Synergy Between Intracoronary Stenting and Abciximab in Improving Angiographic and Clinical Outcomes of Primary Angioplasty in Acute Myocardial Infarction | 2000 | 2.5 | 48 | Citations (PDF) |
| 169 | Should Intensive Cholesterol Lowering Play a Role in the Management of Acute Coronary Syndromes? | 2000 | 2.5 | 6 | Citations (PDF) |
| 170 | Introduction | 2000 | 2.5 | 8 | Citations (PDF) |
| 171 | Is a Mechanical or a Metabolic Approach Superior in the Treatment of Coronary Disease? Results of the Atorvastatin Versus Revascularization (AVERT) Trial. | 2000 | 14.8 | 6 | Citations (PDF) |
| 172 | Identification of Coronary Thrombus With a IIb/IIIa Platelet Inhibitor Radiopharmaceutical, Technetium-99m DMP-444 | 2000 | 24.7 | 35 | Citations (PDF) |
| 173 | Postscripts From the Post Coronary Artery Bypass Graft Trial | 2000 | 24.7 | 13 | Citations (PDF) |
| 174 | A Randomized Controlled Trial of Smoking Cessation Counseling After Myocardial Infarction | 2000 | 3.3 | 161 | Citations (PDF) |
| 175 | Error | American Heart Association Journals | 2000 | 24.7 | 2 | Citations (PDF) |
| 176 | Aggressive Lipid-Lowering Therapy Compared With Angioplasty in Stable Coronary Artery Disease | 1999 | 76.8 | 841 | Citations (PDF) |
| 177 | Cholesterol Lowering | 1999 | 24.7 | 26 | Citations (PDF) |
| 178 | Functional Assessment With Electrocardiographic Gated Single-Photon Emission Computed Tomography Improves the Ability of Technetium-99m Sestamibi Myocardial Perfusion Imaging to Predict Myocardial Viability in Patients Undergoing Revascularization | 1999 | 2.5 | 71 | Citations (PDF) |
| 179 | Impact of Limited Treadmill Exercise on Adenosine Tc-99m Sestamibi Single-Photon Emission Computed Tomographic Myocardial Perfusion Imaging in Coronary Artery Disease | 1999 | 2.5 | 34 | Citations (PDF) |
| 180 | Clinical and Angiographic Characteristics of Exertion-Related Acute Myocardial Infarction | 1999 | 37.2 | 171 | Citations (PDF) |
| 181 | Combined Assessment of Myocardial Perfusion and Left Ventricular Function With Exercise Technetium-99m Sestamibi Gated Single-Photon Emission Computed Tomography Can Differentiate Between Ischemic and Nonischemic Dilated Cardiomyopathy | 1998 | 2.5 | 71 | Citations (PDF) |
| 182 | Acute Coronary Syndromes: Is a Unified Management Strategy Emerging? | 1998 | 12.1 | 0 | Citations (PDF) |
| 183 | Abciximab in Primary Coronary Angioplasty for Acute Myocardial Infarction Improves Short- and Medium-Term Outcomes. | 1998 | 12.1 | 54 | Citations (PDF) |
| 184 | Comparison of Cardiac Troponin I, Creatine Kinase-MB, and Myoglobin for Detection of Acute Ischemic Myocardial Injury in a Swine Model. | 1998 | 2.2 | 77 | Citations (PDF) |
| 185 | Myocardial Cell Death and Apoptosis in Hibernating Myocardium | 1997 | 12.1 | 95 | Citations (PDF) |
| 186 | Impact of Acute Propranolol Administration on Dobutamine-Induced Myocardial Ischemia as Evaluated by Myocardial Perfusion Imaging and Echocardiography | 1997 | 2.5 | 53 | Citations (PDF) |
| 187 | Direct Comparison of Arbutamine and Dobutamine Stress Testing With Myocardial Perfusion Imaging and Echocardiography in Patients With Coronary Artery Disease | 1997 | 2.5 | 9 | Citations (PDF) |
| 188 | Rationale, Design, and Baseline Characteristics of a Trial Comparing Aggressive Lipid Lowering With Atorvastatin Versus Revascularization Treatments (AVERT) | 1997 | 2.5 | 31 | Citations (PDF) |
| 189 | Coronary Angioplasty Induces a Systemic Inflammatory Response | 1997 | 2.5 | 80 | Citations (PDF) |
| 190 | Prognostic Importance of Scintigraphic Left Ventricular Cavity Dilation During Intravenous Dipyridamole Technetium-99m Sestamibi Myocardial Tomographic Imaging in Predicting Coronary Events | 1997 | 2.5 | 79 | Citations (PDF) |
| 191 | Nitroglycerin Enhances the Ability of Dobutamine Stress Echocardiography to Detect Hibernating Myocardium | 1997 | 24.7 | 14 | Citations (PDF) |
| 192 | Lessons From Coronary Atherosclerosis "Regression" Trials. | 1996 | 1.4 | 9 | Citations (PDF) |
| 193 | Review of Cholesterol-Lowering Therapy: Coronary Angiographic and Events Trials | 1996 | 3.2 | 21 | Citations (PDF) |
| 194 | Recombinant Human Growth Hormone, Insulin-Like Growth Factor 1, and Combination Therapy in AIDS-Associated Wasting | 1996 | 12.9 | 133 | Citations (PDF) |
| 195 | Functional and Structural Alterations With 24-Hour Myocardial Hibernation and Recovery After Reperfusion | 1996 | 24.7 | 63 | Citations (PDF) |
| 196 | Effects of Cigarette Smoking on the Angiographic Evolution of Coronary Atherosclerosis | 1996 | 24.7 | 101 | Citations (PDF) |
| 197 | Percentage Change Rather Than Plasma Level of LDL-Cholesterol Determines Therapeutic Response in Coronary Heart Disease | 1995 | 5.0 | 55 | Citations (PDF) |
| 198 | Coronary Arteriography | 1995 | 2.0 | 0 | Citations (PDF) |
| 199 | Antianginal Efficacy and Safety of Controlled-Delivery Diltiazem QD Versus an Equivalent Dose of Immediate-Release Diltiazem TID | 1995 | 4.1 | 3 | Citations (PDF) |
| 200 | Safety of Dipyridamole Testing in 73,806 Patients: The Multicenter Dipyridamole Safety Study | 1995 | 1.8 | 179 | Citations (PDF) |
| 201 | Feasibility of Radiofrequency Powered, Thermal Balloon Ablation of Atrioventricular Bypass Tracts via the Coronary Sinus: In Vivo Canine Studies | 1995 | 1.3 | 128 | Citations (PDF) |
| 202 | 986-77 Does Atropine Completely Abolish the Influence of β-Blockade on the Ischemic Response During Dobutamine Stress Echocardiography? | 1995 | 12.1 | 0 | Citations (PDF) |
| 203 | Randomized Double-Blind Comparison of Two Doses of Hirulog With Heparin as Adjunctive Therapy to Streptokinase to Promote Early Patency of the Infarct-Related Artery in Acute Myocardial Infarction | 1995 | 24.7 | 101 | Citations (PDF) |
| 204 | Effects of Cholesterol Lowering on the Progression of Coronary Atherosclerosis in Women | 1995 | 24.7 | 58 | Citations (PDF) |
| 205 | Oral Verapamil Inhibits Platelet Thrombus Formation in Humans. | 1994 | 24.7 | 42 | Citations (PDF) |
| 206 | Endothelium-Derived Nitric Oxide Attenuates Neutrophil Adhesion to Endothelium Under Arterial Flow Conditions. | 1994 | 4.7 | 58 | Citations (PDF) |
| 207 | A New Look at Coronary Angiograms: Plaque Morphology as a Help to Diagnosis and to Evaluate Outcome | 1994 | 2.0 | 8 | Citations (PDF) |
| 208 | Plaque Stabilization: A Mechanism for the Beneficial Effect of Lipid-Lowering Therapies in Angiography Studies | 1994 | 9.7 | 32 | Citations (PDF) |
| 209 | Efficacy of High Dose Intravenous Heparin for Treatment of Left Ventricular Thrombi With High Embolic Risk. | 1994 | 12.1 | 58 | Citations (PDF) |
| 210 | Localized Intramural Drug Delivery During Balloon Angioplasty Using Hydrogel-Coated Balloons and Pressure-Augmented Diffusion. | 1994 | 12.1 | 73 | Citations (PDF) |
| 211 | Calcium Channel Blockers and Coronary Atherosclerosis: From the Rabbit to the Real World | 1994 | 3.4 | 35 | Citations (PDF) |
| 212 | Are Qualitative Features of Coronary Artery Lesions Useful in Predicting Progression? | 1994 | 0.0 | 0 | Citations (PDF) |
| 213 | Design Features of a Controlled Clinical Trial to Assess the Effect of an HMG CoA Reductase Inhibitor on the Progression of Coronary Artery Disease | 1993 | 3.4 | 13 | Citations (PDF) |
| 214 | A Dose-Response Study of Clentiazem, a Chloro-Derivative of Diltiazem, in Patients With Stable Angina | 1993 | 12.1 | 9 | Citations (PDF) |
| 215 | Methylene Blue Inhibits the Antithrombotic Effect of Nitroglycerin | 1993 | 12.1 | 28 | Citations (PDF) |
| 216 | Effects of Thrombocytopenia and Shear Rate on Neutrophil and Platelet Deposition on Endothelial and Medial Arterial Surfaces. | 1993 | 4.7 | 21 | Citations (PDF) |
| 217 | Aspirin Versus Heparin to Prevent Myocardial Infarction During the Acute Phase of Unstable Angina. | 1993 | 24.7 | 290 | Citations (PDF) |
| 218 | Progression and Regression of Coronary Atherosclerosis: Data From a Controlled Clinical Trial With Nicardipine | 1993 | 0.0 | 2 | Citations (PDF) |
| 219 | Reactivation of Unstable Angina After the Discontinuation of Heparin | 1992 | 76.8 | 448 | Citations (PDF) |
| 220 | Is Thrombolytic Therapy Striking Out in Unstable Angina? | 1992 | 24.7 | 36 | Citations (PDF) |
| 221 | Preoperative and Long-Term Cardiac Risk Assessment Predictive Value of 23 Clinical Descriptors, 7 Multivariate Scoring Systems, and Quantitative Dipyridamole Imaging in 360 Patients | 1992 | 6.7 | 75 | Citations (PDF) |
| 222 | Symptom-Limited Versus Low Level Exercise Testing Before Hospital Discharge After Myocardial Infarction | 1992 | 12.1 | 63 | Citations (PDF) |
| 223 | Prognostic Implications of a Negative Dipyridamole-Thallium Scan: Results in 360 Patients | 1992 | 3.2 | 10 | Citations (PDF) |
| 224 | Measuring Progression and Regression of Coronary Atherosclerosis in Clinical Trials: Problems and Progress | 1992 | 2.0 | 35 | Citations (PDF) |
| 225 | Preoperative Coronary Artery Disease Risk Stratification Based on Dipyridamole Imaging and a Simple Three-Step, Three-Segment Model for Patients Undergoing Noncardiac Vascular Surgery or Major General Surgery | 1992 | 2.5 | 97 | Citations (PDF) |
| 226 | Effect of Diltiazem Slow-Release Formulation on Silent Myocardial Ischemia in Stable Coronary Artery Disease | 1992 | 2.5 | 16 | Citations (PDF) |
| 227 | Percutaneous Mitral Valvuloplasty in Surgical High Risk Patients | 1991 | 12.1 | 36 | Citations (PDF) |
| 228 | Multivariate Clinical Models and Quantitative Dipyridamole-Thallium Imaging to Predict Cardiac Morbidity and Death After Vascular Reconstruction | 1991 | 3.4 | 72 | Citations (PDF) |
| 229 | Regression of Coronary Atherosclerosis: An Achievable Goal? Review of Results From Recent Clinical Trials | 1991 | 3.2 | 17 | Citations (PDF) |
| 230 | Clinical and Angiographic Features and Prognostic Significance of Early Postinfarction Angina With and Without Electrocardiographic Signs of Transient Ischemia | 1991 | 3.2 | 18 | Citations (PDF) |
| 231 | Role of Diltiazem in the Treatment of Silent Myocardial Ischemia | 1991 | 2.5 | 2 | Citations (PDF) |
| 232 | Newer Concepts in the Treatment of Unstable Angina Pectoris | 1991 | 2.5 | 8 | Citations (PDF) |
| 233 | Proischemic Complications of Dihydropyridine Calcium Channel Blockers. | 1991 | 24.7 | 68 | Citations (PDF) |
| 234 | Diltiazem at Reperfusion Reduces Neutrophil Accumulation and Infarct Size in Dogs With Ischaemic Myocardium. | 1991 | 13.5 | 23 | Citations (PDF) |
| 235 | Hemodynamic, Platelet and Clinical Responses to Prostacyclin in Unstable Angina Pectoris | 1990 | 2.5 | 13 | Citations (PDF) |
| 236 | What Is an Antiarrhythmic Drug? From Clinical Trials to Fundamental Concepts | 1990 | 2.5 | 17 | Citations (PDF) |
| 237 | Transient Left Ventricular Cavitary Dilation During Dipyridamole-Thallium Imaging as an Indicator of Severe Coronary Artery Disease | 1990 | 2.5 | 68 | Citations (PDF) |
| 238 | Effects of Nitroglycerin at Therapeutic Doses on Platelet Aggregation in Unstable Angina Pectoris and Acute Myocardial Infarction | 1990 | 2.5 | 145 | Citations (PDF) |
| 239 | Postoperative Myocardial Infarction and Cardiac Death: Predictive Value of Dipyridamole-Thallium Imaging and Five Clinical Scoring Systems Based on Multifactorial Analysis | 1990 | 6.7 | 62 | Citations (PDF) |
| 240 | A Controlled Clinical Trial to Assess the Effect of a Calcium Channel Blocker on the Progression of Coronary Atherosclerosis. | 1990 | 24.7 | 388 | Citations (PDF) |
| 241 | Left-to-Right Atrial Shunting After Percutaneous Mitral Valvuloplasty. Incidence and Long-Term Hemodynamic Follow-Up. | 1990 | 24.7 | 94 | Citations (PDF) |
| 242 | Is Dipyridamole-Thallium Imaging Preferable to Submaximal Exercise Thallium Testing for Risk Stratification After Thrombolysis? | 1990 | 3.4 | 6 | Citations (PDF) |
| 243 | Influence of Fibrinolysis and Percutaneous Transluminal Coronary Angioplasty on the Frequency of Ventricular Premature Complexes | 1989 | 2.5 | 25 | Citations (PDF) |
| 244 | Comparison by Quantitative Angiographic Assessment of Coronary Stenoses of One View Showing the Severest Narrowing to Two Orthogonal Views | 1989 | 2.5 | 62 | Citations (PDF) |
| 245 | Usefulness of the Severity and Extent of Reversible Perfusion Defects During Thallium-Dipyridamole Imaging for Cardiac Risk Assessment Before Noncardiac Surgery | 1989 | 2.5 | 83 | Citations (PDF) |
| 246 | Acute Pulmonary Edema Caused by Prolonged Myocardial Stunning After Dipyridamole-Thallium Imaging | 1989 | 3.2 | 11 | Citations (PDF) |
| 247 | Limited Usefulness of Intermittent Nitroglycerin Patches in Stable Angina | 1989 | 12.1 | 49 | Citations (PDF) |
| 248 | Acute Pulmonary Edema Caused by Prolonged Myocardial Stunning After Dipyridamole-Thallium Imaging | 1989 | 3.2 | 1 | Citations (PDF) |
| 249 | Treatment of Recurrent Restenosis With Repeat Percutaneous Transluminal Coronary Angioplasty | 1988 | 2.5 | 16 | Citations (PDF) |
| 250 | Massive Mitral Regurgitation Caused by Tearing of the Anterior Leaflet During Percutaneous Mitral Balloon Valvuloplasty | 1988 | 3.2 | 21 | Citations (PDF) |
| 251 | Aspirin, Heparin, or Both to Treat Acute Unstable Angina | 1988 | 76.8 | 1,249 | Citations (PDF) |
| 252 | Regression of Coronary Atherosclerosis | 1988 | 15.5 | 2 | Citations (PDF) |
| 253 | Restenosis and Progression of Coronary Atherosclerosis After Coronary Angioplasty | 1988 | 12.1 | 52 | Citations (PDF) |
| 254 | Multiple Coronary Angioplasty: A Model to Discriminate Systemic and Procedural Factors Related to Restenosis | 1988 | 12.1 | 92 | Citations (PDF) |
| 255 | Long-Term Prognosis After Myocardial Infarction in Patients With Previous Coronary Artery Bypass Surgery | 1988 | 12.1 | 50 | Citations (PDF) |
| 256 | Pathophysiology of Unstable Angina Pectoris: Clinical, Angiographic and Therapeutic Observations | 1988 | 0.0 | 0 | Citations (PDF) |
| 257 | Design Features of a Controlled Clinical Trial to Assess the Effect of a Calcium Entry Blocker Upon the Progression of Coronary Artery Disease | 1987 | 3.4 | 39 | Citations (PDF) |
| 258 | Comparative Antianginal Effects of Nisoldipine and Nifedipine in Patients With Chronic Stable Angina | 1987 | 3.4 | 18 | Citations (PDF) |
| 259 | Uncomplicated Non-Q Wave Infarction Caused by Total Obstruction of the Left Main Coronary Artery | 1987 | 3.4 | 8 | Citations (PDF) |
| 260 | ‘Second Generation’ Dihydropyridine Calcium Antagonists | 1987 | 15.5 | 86 | Citations (PDF) |
| 261 | Early Results, Complications and Restenosis Rates After Multilesion and Multivessel Percutaneous Transluminal Coronary Angioplasty | 1987 | 2.5 | 29 | Citations (PDF) |
| 262 | Previous Coronary Artery Bypass Grafting as an Adverse Prognostic Factor in Unstable Angina Pectoris | 1986 | 2.5 | 38 | Citations (PDF) |
| 263 | Long-Term Reproducibility and Significance of Provokable Ventricular Arrhythmias After Myocardial Infarction | 1986 | 12.1 | 42 | Citations (PDF) |
| 264 | Exercise Testing After Myocardial Infarction: A Perspective | 1986 | 12.1 | 2 | Citations (PDF) |
| 265 | Percutaneous Transluminal Coronary Angioplasty for the Treatment of Variant Angina | 1985 | 12.1 | 57 | Citations (PDF) |
| 266 | Comparison of Clinical Variables and Variables Derived From a Limited Predischarge Exercise Test as Predictors of Early and Late Mortality After Myocardial Infarction | 1985 | 12.1 | 120 | Citations (PDF) |
| 267 | Coronary Angiographic Significance of Left Anterior Fascicular Block During Acute Myocardial Infarction | 1985 | 12.1 | 27 | Citations (PDF) |
| 268 | A Dose-Ranging, Placebo-Controlled, Double-Blind Trial of Nisoldipine in Effort Angina: Duration and Extent of Antianginal Effects | 1985 | 12.1 | 56 | Citations (PDF) |
| 269 | Serial Exercise Testing in Patients With Effort Angina: Variable Tolerance, Fixed Threshold | 1985 | 12.1 | 52 | Citations (PDF) |
| 270 | A Randomized Study Comparing Propranolol and Diltiazem in the Treatment of Unstable Angina | 1985 | 12.1 | 151 | Citations (PDF) |
| 271 | Factors Associated With Progression of Coronary Artery Disease in Patients With Normal or Minimally Narrowed Coronary Arteries | 1985 | 2.5 | 57 | Citations (PDF) |
| 272 | Exercise Testing in the Early Period After Myocardial Infarction in the Evaluation of Prognosis | 1984 | 1.4 | 3 | Citations (PDF) |
| 273 | Is Progression of Coronary Artery Disease Occurring at Bouts or as a Continuous Process? Serial Cineangiographic Studies in 44 Patients | 1984 | 0.9 | 7 | Citations (PDF) |
| 274 | Clinical and Angiographic Factors Associated With Coronary Artery Disease Progression of Coronary Artery Disease | 1984 | 12.1 | 95 | Citations (PDF) |
| 275 | Myocardial Infarction in Patients With Previous Coronary Artery Bypass Surgery | 1984 | 12.1 | 18 | Citations (PDF) |
| 276 | Ventricular Arrhythmias During Ergonovine-Induced Episodes of Variant Angina | 1984 | 3.4 | 28 | Citations (PDF) |
| 277 | Circadian Variation in Variant Angina | 1984 | 2.5 | 124 | Citations (PDF) |
| 278 | Calcium Antagonists | 1983 | 15.5 | 52 | Citations (PDF) |
| 279 | The Ergonovine Test — To Catch a Leprechaun | 1983 | 3.2 | 0 | Citations (PDF) |
| 280 | Sudden Death in Two Patients With Variant Angina and Apparently Minimal Fixed Coronary Stenoses | 1983 | 1.5 | 11 | Citations (PDF) |
| 281 | Spontaneous Remission Is a Frequent Outcome of Variant Angina | 1983 | 12.1 | 71 | Citations (PDF) |
| 282 | Unstable Angina and Progression of Coronary Atherosclerosis | 1983 | 76.8 | 243 | Citations (PDF) |
| 283 | Symptomatic Coronary Artery Spasm Following Radiotherapy for Hodgkin's Disease | 1983 | 5.9 | 27 | Citations (PDF) |
| 284 | Clinical Characteristics of Patients With Variant Angina Complicated by Myocardial Infarction or Death Within 1 Month | 1982 | 2.5 | 55 | Citations (PDF) |
| 285 | Clinical Manifestations and Pathophysiology of Myocardial Ischemia With Special Reference to Coronary Artery Spasm and the Role of Slow Channel Calcium Blockers | 1982 | 9.7 | 15 | Citations (PDF) |
| 286 | S-T Segment Elevation and Coronary Spasm in Response to Exercise | 1981 | 2.5 | 49 | Citations (PDF) |
| 287 | Ergonovine Testing to Detect Spontaneous Remissions of Variant Angina During Long-Term Treatment With Calcium Antagonist Drugs | 1981 | 2.5 | 113 | Citations (PDF) |
| 288 | Provocative Testing With Ergonovine to Assess the Efficacy of Treatment With Nifedipine, Diltiazem and Verapamil in Variant Angina | 1981 | 2.5 | 106 | Citations (PDF) |
| 289 | Is Variant Angina the Coronary Manifestation of a Generalized Vasospastic Disorder? | 1981 | 76.8 | 268 | Citations (PDF) |
| 290 | Hemodynamics and Coronary Flow Following Diltiazem Administration in Anesthetized Dogs and in Humans | 1980 | 5.9 | 86 | Citations (PDF) |
| 291 | Hemodynamics and Coronary Flow Following Diltiazem Administration in Anesthetized Dogs and in Humans | 1980 | 5.9 | 71 | Citations (PDF) |
| 292 | Hemodynamic Effects of a Single Oral Dose of Nifedipine Following Acute Myocardial Infarction. | 1980 | 5.9 | 31 | Citations (PDF) |
| 293 | Refractory Variant Angina Controlled With Combined Drug Therapy in a Patient With a Single Coronary Artery | 1980 | 0.7 | 9 | Citations (PDF) |
| 294 | Ergonovine Testing in a Coronary Care Unit | 1980 | 2.5 | 94 | Citations (PDF) |
| 295 | Prognostic Value of Exercise Testing Soon After Myocardial Infarction | 1979 | 76.8 | 726 | Citations (PDF) |
| 296 | Recurrence of Prinzmetal Angina Seven Years Following Aortocoronary Bypass Surgery: A Clinical and Angiographic Follow-Up | 1979 | 0.7 | 5 | Citations (PDF) |
| 297 | Chronic Oral Vasodilator Therapy to Control Heart Failure in Postinfarction Ventricular Septal Defect | 1979 | 0.7 | 0 | Citations (PDF) |
| 298 | Clinical Predictors of Angina Following Myocardial Infarction | 1979 | 3.2 | 34 | Citations (PDF) |
| 299 | Left Main Coronary Artery Stenosis in Young Patients | 1979 | 5.9 | 12 | Citations (PDF) |
| 300 | Hospital Treatment of Congestive Heart Failure: Management According to Hemodynamic Profile | 1978 | 3.2 | 70 | Citations (PDF) |
| 301 | Coronary Artery Disease in Young Women: Clinical and Angiographic Features and Correlation With Risk Factors | 1978 | 2.5 | 56 | Citations (PDF) |
| 302 | Myocardial Ischemia: Detection and Quantitation | 1978 | 12.9 | 13 | Citations (PDF) |
| 303 | Aortic and Mitral Valve Replacement in a Patient With Osteogenesis Imperfecta | 1977 | 5.9 | 16 | Citations (PDF) |
| 304 | Early Changes in Regional and Global Left Ventricular Function Induced by Graded Reductions in Regional Coronary Perfusion | 1977 | 2.5 | 183 | Citations (PDF) |
| 305 | Regional Mechanical Function in Acute Myocardial Ischemia | 1977 | 0.5 | 0 | Citations (PDF) |
| 306 | Cardiac Features of an Unusual X-Linked Humeroperoneal Neuromuscular Disease | 1975 | 76.8 | 92 | Citations (PDF) |
| 307 | Long-Term Prognosis of Patients With Incomplete Bilateral Bundle Branch Block Complicating Acute Myocardial Infarction: Role of Cardiac Pacing | 1974 | 2.5 | 36 | Citations (PDF) |